NCT00186498 - Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 29, 2008

Conditions

Depressive Disorder, Major

Interventions

DRUG

memantine

Patients received a memantine containing capsule starting the day before ECT begins and while receiving ECT

DRUG

Placebo Oral Capsule

Patients received a placebo capsule starting the day before ECT begins and while receiving ECT

Trial Locations (1)

Stanford University School of Medicine, Stanford